SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant

Por Yoriyuki Konno, Izumi Kimura, Keiya Uriu, Masaya Fukushi, Takashi Irie, Yoshio Koyanagi, Daniel Sauter, Robert J. Gifford, So Nakagawa, Kei Sato
Publicado em 2020-09-01

Antithetic effect of interferon-α on cell-free and cell-to-cell HIV-1 infection.

Por Ryuichi Kumata, Shoya Iwanami, Katrina B Mar, Yusuke Kakizoe, Naoko Misawa, Shinji Nakaoka, Yoshio Koyanagi, Alan S Perelson, John W Schoggins, Shingo Iwami, Kei Sato
Publicado em 2022-04-01

Antithetic effect of interferon-α on cell-free and cell-to-cell HIV-1 infection

Por Ryuichi Kumata, Shoya Iwanami, Katrina B. Mar, Yusuke Kakizoe, Naoko Misawa, Shinji Nakaoka, Yoshio Koyanagi, Alan S. Perelson, John W. Schoggins, Shingo Iwami, Kei Sato
Publicado em 2022-04-01

CKIP-1 is an intrinsic negative regulator of T-cell activation through an interaction with CARMA1.

Por Takashi Sakamoto, Masayuki Kobayashi, Kohei Tada, Masanobu Shinohara, Katsuhiro Io, Kayoko Nagata, Fumie Iwai, Yoko Takiuchi, Yasuyuki Arai, Kouhei Yamashita, Keisuke Shindo, Norimitsu Kadowaki, Yoshio Koyanagi, Akifumi Takaori-Kondo
Publicado em 2014-01-01

Host factor SAMHD1 restricts DNA viruses in non-dividing myeloid cells.

Por Joseph A Hollenbaugh, Peter Gee, Jonathon Baker, Jonathon Baker, Michele B Daly, Sarah M Amie, Jessica Tate, Natsumi Kasai, Yuka Kanemura, Dong-Hyun Kim, Brian M Ward, Yoshio Koyanagi, Baek Kim
Publicado em 2013-01-01